• Home  /    Quality System

    1、Lixin Pharmaceutical was approved by U.S. Food and Drug Administration (FDA) in 2010, and had a review with zero defect in 2015.

    2、Lixin Pharmaceutical was approved by European Directorate for the Quality of Medicines (EDQM), European Medicines Agency (EMA) in Oct, 2016.

    Hydrochlorothiazide-CEP-certificate Dacarbazine-CEP-certificate Indapamide-CEP-certificate

    3、A number of products receive certificates of GMP by China Food and Drug Administration (NMPA)

    亚洲色欲久久久久综合网_毛片 无码 国产 午夜视频_久久久久精品免费毛片_男女18禁一区二区三区囗H毛片